Dr. Sasha Bernatsky and her team will be sharing their expertise with the Canadian Agency of Drugs and Technologies in Health's (CADTH) post market drug evaluation network!

The Canadian Network for Advanced Interdisciplinary Methods for comparative effectiveness research (CAN-AIM), led by Dr. Sasha Bernatsky and hosted by the Research Institute of the McGill University Health Centre, was selected by Canadian Agency of Drugs and Technologies in Health as a collaborator for their Post-Market Drug Evaluation Network (PMDE). Collaborators will bring additional expertise to the PMDE Network and will respond to decision-makers’ queries by providing expertise and evidence in the post-market space.

For more info visit the CADTH website.